Xylem Inc. (XYL) Receives Consensus Recommendation of “Buy” from Analysts
Xylem Inc. (NYSE:XYL) has been given an average rating of “Buy” by the sixteen research firms that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $66.90.
Several brokerages have weighed in on XYL. Canaccord Genuity reaffirmed a “hold” rating and set a $65.00 target price on shares of Xylem in a research note on Wednesday, November 1st. Seaport Global Securities reissued a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Cowen and Company reissued an “outperform” rating and set a $70.00 price target (up previously from $60.00) on shares of Xylem in a research report on Wednesday, August 9th. BMO Capital Markets increased their price target on shares of Xylem from $74.00 to $76.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st. Finally, Oppenheimer Holdings, Inc. increased their price target on shares of Xylem from $66.00 to $75.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st.
Xylem (NYSE:XYL) traded down $0.03 during trading on Monday, hitting $66.25. 504,000 shares of the stock were exchanged, compared to its average volume of 1,246,918. Xylem has a fifty-two week low of $46.67 and a fifty-two week high of $67.64. The stock has a market capitalization of $11,903.89, a price-to-earnings ratio of 28.94, a price-to-earnings-growth ratio of 1.85 and a beta of 1.16. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.76 and a quick ratio of 1.26.
Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.01. Xylem had a net margin of 6.85% and a return on equity of 17.74%. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same quarter in the prior year, the firm earned $0.54 earnings per share. The company’s revenue for the quarter was up 33.2% compared to the same quarter last year. equities analysts expect that Xylem will post 2.39 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Thursday, November 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Wednesday, November 1st. Xylem’s payout ratio is currently 41.86%.
TRADEMARK VIOLATION NOTICE: This report was first posted by Daily Political and is owned by of Daily Political. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/11/xylem-inc-xyl-receives-consensus-recommendation-of-buy-from-analysts.html.
In other Xylem news, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $66.25, for a total value of $2,497,625.00. Following the transaction, the director now directly owns 58,831 shares of the company’s stock, valued at approximately $3,897,553.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the sale, the insider now directly owns 61,979 shares in the company, valued at $4,078,837.99. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by insiders.
Hedge funds have recently bought and sold shares of the stock. Teachers Advisors LLC grew its stake in Xylem by 12.7% during the 1st quarter. Teachers Advisors LLC now owns 273,420 shares of the industrial products company’s stock worth $13,731,000 after buying an additional 30,811 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new position in Xylem during the first quarter valued at about $314,000. Clearbridge Investments LLC boosted its stake in Xylem by 682.9% during the first quarter. Clearbridge Investments LLC now owns 64,290 shares of the industrial products company’s stock valued at $3,229,000 after buying an additional 56,078 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in Xylem by 10.0% during the first quarter. Nomura Asset Management Co. Ltd. now owns 23,010 shares of the industrial products company’s stock valued at $1,155,000 after buying an additional 2,100 shares in the last quarter. Finally, Charter Trust Co. bought a new position in Xylem during the second quarter valued at about $203,000. 86.49% of the stock is currently owned by institutional investors and hedge funds.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.